Background Lung adenocarcinoma (LUAD) is the one of the most common subtypes in lung
cancer. Although various targeted therapies have been used in the clinical practice, the 5 …

Objective Lung adenocarcinoma (LUAD) is the most prevalent lung cancer subtype, but its
immune infiltration features are not comprehensively understood. To address the issue, the …

That impairment of immune response may actually play an active role in the development of
NSCLC, it is well anticipated by the beneficial effects of tumor lymphocytic infiltration on the …

Apatinib plus chemotherapy demonstrates good efficacy in multiple advanced carcinomas;
however, its use in patients with advanced lung adenocarcinoma (LUAD) has not yet been …

Increasing evidence imputes cancer progression and resistance to therapy to intra-tumor
molecular heterogeneity set off by cancer cell plasticity. Re-activation of developmental …

Background: Lipid metabolism plays a pivotal role in cancer progression and metastasis.
This study aimed to investigate the prognostic value of lipid metabolism-related genes …

As an important element in regulating the tumor microenvironment (TME), integrin plays a
key role in tumor progression. This study aimed to establish prognostic signatures to predict …

The most common type of lung cancer tissue is lung adenocarcinoma. The TCGA‐LUAD
cohort retrieved from the TCGA dataset was considered the internal training cohort, while …

Lung adenocarcinoma (LUAD) is the most common type of non-small-cell lung cancer, and
a subset of patients with early-stage LUAD experience relapses and adverse prognosis …